Precision BioLogic Announces Strategic Acquisition of George King Bio-Medical Precision BioLogic Inc. has strategically acquired George King Bio-Medical, enhancing its diagnostic capabilities for bleeding disorders.

Precision BioLogic Announces Strategic Acquisition of George King Bio-Medical #Canada #Halifax #Blood_Disorders #Precision_BioLogic #George_King

A Strategic Acquisition to Enhance Hemostasis Diagnostic Solutions Precision BioLogic Inc. has announced a strategic acquisition of George King Bio-Medical, aiming to enhance their hemostasis diagnostic offerings and services.

A Strategic Acquisition to Enhance Hemostasis Diagnostic Solutions #USA #Halifax #hemostasis #Precision_BioLogic #George_King_Bio-Medical

Precision BioLogic's Strategic Acquisition of George King Bio-Medical Enhances Hemostasis Diagnostics Precision BioLogic Inc. has announced its strategic acquisition of George King Bio-Medical, strengthening their commitment to hemostasis diagnostics and patient care.

Precision BioLogic's Strategic Acquisition of George King Bio-Medical Enhances Hemostasis Diagnostics #USA #Halifax #hemostasis #Precision_BioLogic #George_King_Bio-Medical

Precision BioLogic Expands with Strategic Acquisition of George King Bio-Medical Precision BioLogic has successfully acquired George King Bio-Medical, enhancing its hemostasis diagnostic product offerings and commitment to bleeding disorders.

Precision BioLogic Expands with Strategic Acquisition of George King Bio-Medical #USA #Halifax #hemostasis #Precision_BioLogic #George_King

Precision BioLogic Enhances Market Position with George King Bio-Medical Acquisition Precision BioLogic, a key player in hemostasis diagnostics, has announced its acquisition of George King Bio-Medical, emphasizing their commitment to innovation in bleeding disorder solutions.

Precision BioLogic Enhances Market Position with George King Bio-Medical Acquisition #USA #Halifax #hemostasis #Precision_BioLogic #George_King_Bio-Medical

Precision BioLogic Enhances Hemophilia Testing with New CRYOcheck Assay to Meet Emerging Treatment Needs Precision BioLogic is transforming hemophilia testing with enhanced accuracy in its CRYOcheck assay, accommodating new therapies like Mim8 to improve patient care.

Precision BioLogic Enhances Hemophilia Testing with New CRYOcheck Assay to Meet Emerging Treatment Needs #USA #Halifax #Hemophilia #Precision_BioLogic #CRYOcheck

Precision BioLogic Advances Hemophilia Testing with Enhanced CRYOcheck Reagent Precision BioLogic Inc. announces improved applications for their CRYOcheck VIII reagent, ensuring labs can efficiently manage emerging hemophilia treatments.

Precision BioLogic Advances Hemophilia Testing with Enhanced CRYOcheck Reagent #USA #Halifax #Hemophilia #Precision_BioLogic #CRYOcheck_VIII

Precision BioLogic Transforms Hemophilia Testing with Innovative Assay Updates Precision BioLogic announces enhancements to its CRYOcheck Chromogenic Factor VIII assay, crucial for advancing hemophilia treatment monitoring and diagnostics.

Precision BioLogic Transforms Hemophilia Testing with Innovative Assay Updates #USA #Halifax #Hemophilia #Precision_BioLogic #CRYOcheck

Precision BioLogic Enhances Hemophilia Testing with New Assay Capabilities Precision BioLogic Inc. has expanded its CRYOcheck Chromogenic Factor VIII assay to improve hemophilia testing amidst new treatments. This innovation promises better diagnostics for labs.

Precision BioLogic Enhances Hemophilia Testing with New Assay Capabilities #USA #Halifax #Precision_BioLogic #CRYOcheck #Hemophilia_Testing